PBM re­forms fail to make the cut as Sen­ate pass­es Trump’s mega­bill

Ef­forts to rein in phar­ma­cy ben­e­fit man­agers, for which drug­mak­ers have been build­ing bi­par­ti­san sup­port over the years, were left out of the Sen­ate-passed ver­sion …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.